Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank Europe $ 2,000.00
spinner
Single User Europe $ 3,100.00
spinner
Multiple User Europe $ 4,600.00
spinner
Corporate UserEurope $ 6,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Europe Hemostasis Diagnostics Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023


 

Available formats:    

StumbleUponEmail

Europe Hemostasis Diagnostics Market: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Geography – Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Market Outline: Europe Hemostasis Diagnostics Market

 

Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.

 

Market Dynamics: Europe Hemostasis Diagnostics Market

Increase in the prevalence of hemostasis related disease in Europe countries (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), rise in number of surgery cases, rise in R&D investment for novel tests and devices innovation, and well developed healthcare infrastructure are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market.

 

Market Scope: Europe Hemostasis Diagnostics Market

Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user

Based on the product type, the market is segmented into the following:

  • Systems
  • Consumables
  • Point-of-Care Testing Devices

Based on the test type, the market is segmented into the following:

  • Fibrinogen Test
  • Activated Clotting Time
  • Platelet Function
  • Prothrombin Time
  • Heparin & Protamine Dose-Response Test For ACT
  • Activated Partial Thromboplastin Time
  • Anti-Factor Xa
  • Other Coagulation Tests

Based on the technology, the market is segmented into the following:

  • Optical
  • Mechanical
  • Electrochemical
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others (POC)

 

 Regional Analysis: Europe Hemostasis Diagnostics Market

Geographically, Europe hemostasis diagnosis market is segmented into U.K., France, Germany, Russia, Spain, Italy, Poland, and Rest of Europe. U.K. hemostasis diagnostics market accounted for significant share, which is attributed to rise in prevalence of hemophilia (according to World Federation of Hemophilia Global Survey 2010, approximately 6,573 people are suffering from hemophilia), increase in prevalence of cardiovascular diseases, and adoption of newer technologies are expected to propel the market in U.K. France hemostasis diagnostics market is growing due to rise in funding for launching test kits. For instance, in March 2016, Emosis, a French company raised 1 Mn Euros funding from Cap Innov’Est for the development of hemostasis test kits. Germany hemostasis market growth driven by increase in the R&D for innovation of newer products, rise in prevalence of hemophilia disease, and expansion of business by market players in the country. Russia hemostasis diagnostics market is rising due to organization of training programs for doctors on coagulation testing by market players.

 

Competition Assessment: Europe Hemostasis Diagnostics Market

Some of the players in the Europe hemostasis diagnostics market include:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc.  (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (U.S.)
  • Instrumentation Laboratory (U.S.)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)
  • Emosis Diagnostics (France)

 

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and start-up’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  1. Executive Summary
  2. Europe Hemostatsis Diagnostic Market Introduction
    • Europe Hemostatsis Diagnostic Market – Taxonomy
    • Europe Hemostatsis Diagnostic Market –Definitions
      • Product Type
      • Test Type
      • Technology Type
      • End-User Type
  1. Europe Hemostatsis Diagnostic Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Europe Hemostatsis Diagnostic Market Dynamics – Factors Impact Analysis
    • Europe Hemostatsis Diagnostic Market – Regulations
      • U.S.
      • Europe
  1. Europe Hemostatsis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013-2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  2. Europe Hemostatsis Diagnostic Market, By Product Type, 2013-2017 and Forecast, 2018 – 2024
    • Systems
      • Market Analysis, 2013-2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Consumables
      • Market Analysis, 2013-2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Point-of-Care Taking Devices
      • Market Analysis, 2013-2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Europe Hemostatsis Diagnostic Market Forecast, By Test Type, 2013-2017 and Forecast, 2018 – 2024
    • Fibrinogen Test
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Activated Clotting Time
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Platelet Function
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prothrombin Time
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Heparin & Protamine Dose-Response Test For ACT
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Activated Partial Thromboplastin Time
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-Factor Xa
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other Coagulation Tests
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Europe Hemostatsis Diagnostic Market Forecast, By Technology Type, 2013-2017 and Forecast, 2018 – 2024
    • Optical
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Mechanical
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Electrochemical
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Europe Hemostatsis Diagnostic Market Forecast, By End User, 2013-2017 and Forecast, 2018 – 2024
    • Hospitals
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centres
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Europe Hemostatsis Diagnostic Market Forecast, By Region, 2013-2017 and Forecast, 2018 – 2024
    • U.K.
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • France
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Germany
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Russia
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Spain
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Italy
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Poland
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Rest of Europe
      • Market Analysis, 2013-2017 and Forecast, 2018-2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

Market Opportunity Analysis

  • Europe Hemostatsis Diagnostic Market – Opportunity Analysis Index, By Modality Type, By Application, By End-User, and Region, 2013-2017 – 2024
  1. United Kingdom Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • United Kingdom Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • United Kingdom Hemostasis Diagnostics Market Dynamics – Trends
  2. France Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • France Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • France Hemostasis Diagnostics Market Dynamics – Trends
  3. Germany Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Germany Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • Germany Hemostasis Diagnostics Market Dynamics – Trends
  4. Russia Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Russia Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • Russia Hemostasis Diagnostics Market Dynamics – Trends
  5. Spain Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Spain Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • Spain Hemostasis Diagnostics Market Dynamics – Trends
  6. Italy Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Italy Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • Italy Hemostasis Diagnostics Market Dynamics – Trends
  7. Poland Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Poland Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • Poland Hemostasis Diagnostics Market Dynamics – Trends
  8. Rest of Europe Hemostasis Diagnostic Market Analysis, 2013-2017 and Forecast, 2018 – 2024
    • Product Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care Testing Devices
    • Test Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin &Protamine Dose-Response Test for ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-User Analysis (2013-2017) and Forecast 2018-2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Rest of Europe Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, and By End-User, 2013-2017 – 2024
    • Rest of Europe Hemostasis Diagnostics Market Dynamics – Trends
  9. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Hoffmann-La Roche Ltd. (Switzerland)
      • Sysmex Corporation (Japan)
      • Abbott Laboratories (U.S.)
      • Alere Inc. (U.S.)
      • Nihon Kohden Corporation (Japan)
      • Siemens Healthineers (Germany)
      • Danahar Corporation (U.S.)
      • Instrumental Laboratory (U.S.)
      • Grifols SA (Spain)
      • Beckman Coulter, Inc. (U.S.)
      • Emosis Diagnostics (France)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553